Questex, a leading global business information and events company, today announced it has acquired ExL Events Inc., expanding its presence in the global pharmaceutical, life-science and health-care markets.
ExL Events, founded in 2004 as ExL Pharma, is the industry leader in developing innovative, educational conferences that serve the pharmaceutical, life-science and health-care communities. Kerry Gumas, Questex president and chief executive officer, said ExL will complement the services currently provided to those markets by Questex’s Fierce Life Science & Healthcare group of digital media titles and events.
The founders of ExL Events, Bryon Main, president & chief executive officer, and Ethan Denkensohn, chief financial & operating officer, will continue to lead the organization and retain their existing staff. ExL Events, which will continue to operate from its New York headquarters, produces more than 70 annual events in the United States, Europe and Asia for pharmaceutical, biotechnology, medical device, diagnostics and contract-research organizations, hospitals and physicians, among others.
“We are pleased to welcome Bryon, Ethan and the entire ExL Events team to the company,” said Gumas. “They have done an excellent job in building ExL Events into a high-service, high-value producer of events, which we believe will be well complemented by our industry-leading portfolio of digital media titles serving the industry.
“ExL has consistently grown its revenue and EBITDA at double-digit rates over the last five years, and we’ve seen the business continue to scale well due to the strong competencies of the team and systems they have put in place.”
Financial terms of the agreement were not released
